Диссертация (1140724), страница 14
Текст из файла (страница 14)
Serial changes in sexualfunction following holmium laser enucleation of the prostate: a short-term followup study. Korean J Urol. 2012;53:104–8.13053) Jung JH, Jae SU, Kam SC, Hyun JS. Correlation between Lower Urinary TractSymptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact oftreatment of LUTS on sexual function. J Sex Med.2009;6:2299–304.54) Katsumi Shigemura, Kazushi Tanaka, Takahiro Haraguchi, FukashiYamamichi, Mototsugu Muramaki, Hideaki Miyake, Masato Fujisawa.Postoperative Infectious Complications in Our Early Experience With HolmiumLaser Enucleation of the Prostate for Benign Prostatic Hyperplasia. Korean J Urol.Mar 2013; 54(3): 189–193.55) Kim M, Lee HE, Oh SJ (2013) Technical Aspects of Holmium LaserEnucleation of the Prostate for Benign Prostatic Hyperplasia. Korean J Urol 54:570–579.56) Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laserenucleation of the prostate versus transurethral electrocautery resection of theprostate: a randomized prospective trial in 200 patients.
J Urol 2004; 172: 1012–6.57) Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostateversus open prostatectomy for prostates greater than 100 g: 5-year follow-upresults of a randomized clinical trial. Eur Urol 2008; 53: 160–6.58) Kuo HC, Chang SC, Hsu T (1993) Predictive factors for successful surgicaloutcome of benign prostatic hypertrophy. Eur Urol 24: 12–19.59) Kuo RL, Kim SC, Lingeman JE et al.
Holmium laser enucleation of prostate(HoLEP): the Methodist hospital experience with greater than 75 gramenucleations. J Urol 2003; 170: 149–52.60) Kuo RL, Paterson RF, Kim SC, et al: Holmium laser enucleation of theprostate (HoLEP): a technical update. World J Surg Oncol 1: 6–14, 2003.61) Kuo RL, Paterson RF, Siqueira TM Jr, Watkins SL, Simmons GR, et al.(2003) Holmium laser enucleation of the prostate: morbidity in a series of 206patients. Urology 62: 59–63.62) Lai J., Xia Q., Xu S., Zheng D., Zhao G., Guan F. Transurethral bipolarplasmakinetic prostatectomy for benign prostatic hyperplasia. zhonghua NanKeXue 2004; 10(7): 488-490.13163) Lane IF Bae J Eltabey MA (2000) Diagnosis and management of urinaryretention.
The Vet Clin North Am Small Anim Pract 30: 25–57.64) Lee SH, Chung BH, Kim CS, Lee HM, Kim CI, Yoo TK, et al. Survey onbenign prostatic hyperplasia distribution and treatment patterns for men with lowerurinary tract symptoms visiting urologists at general hospitals in Korea: aprospective, non-controlled, observational cohort study. Urology. 2012;79:1379–1384.65) Liao CH, Chiang HS, Yu HJ. Serum testosterone levels significantly correlatewith nocturia in men aged 40-79 years. Urology. 2011;78:631–5.66) Martin AD, Nunez RN, Humphreys MR.
Bleeding after holmium laserenucleation of the prostate: lessons learned the hard way.BJU Int. 2011 Feb;107(3):433-7.67) Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE. Holmium laserenucleation of the prostate for prostates of >125 mL.BJU Int 2006; 97: 81–4.68) McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, et al.(2011) Update on AUA guideline on the management of benign prostatichyperplasia. J Urol 185: 1793–1803.69) Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, and Youn SooJeon. Holmium Laser Enucleation of the Prostate is Effective in the Treatment ofSymptomatic Benign Prostatic Hyperplasia of Any Size Including a SmallProstate.
Korean J Urol. Nov 2014; 55(11): 737–741.70) Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al.Holmium laser enucleation versus transurethral resection of the prostate: resultsfrom a 2-center, prospective, randomized trial in patients with obstructive benignprostatic hyperplasia. J Urol. 2004;172(5 Pt 1):1926–1929.71) Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al.Holmium laser enucleation versus transurethral resection of the prostate: resultsfrom a 2-center prospective randomized trial in patients with obstructive benignprostatic hyperplasia. J Urol. 2008;179(5 Suppl):S87–S90.13272) Moody JA, Lingeman JE. Holmium laser enucleation for prostate adenomagreater than 100 gm: comparison to open prostatectomy.
J Urol 2001; 165: 459–62.73) Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, et al. Sexual functionafter transurethral resection of the prostate (TURP): results of an independentprospective multicentre assessment of outcome. Eur Urol.2007;52:510–574) Nakamura M, Fujimura T, Nagata M, Hosoda C, Suzuki M, et al. Associationbetween lower urinary tract symptoms and sexual dysfunction assessed using thecore lower urinary tract symptom score and International Index of ErectileFunction-5 questionnaires. Aging Male. 2012;15:111–4.75) Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, et al. A reviewof the recent evidence (2006-2008) for 532-nm photoselective laser vaporisationand holmium laser enucleation of the prostate.
Eur Urol.2009;55:1345–57.76) Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, et al.(2013) EAU guidelines on the treatment and follow-up of non-neurogenic malelower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140.77) Okamura K, Nojiri Y, Seki N, Arai Y, Matsuda T, et al. (2011) Perioperativemanagement of transurethral surgery for benign prostatic hyperplasia: Anationwide survey in Japan.
Int J Urol 30: 304–310.78) Peterson MD, Matlaga BR, Kim SC, Kuo RL, Soergel TM, et al.(2005) Holmium laser enucleation of the prostate for men with urinary retention. JUrol 174: 998–1001.79) Placer J, Gelabert-Mas A, Vallmanya F, Manresa JM, Menendez V, et al.(2009) Holmium laser enucleation of prostate: outcome and complications of selftaught learning curve. Urology 73: 1042–1048.80) Rieken M, EbingerMundorff N, Bonkat G, Wyler S, Bachmann A(2010) Complications of laser prostatectomy: a review of recent data. World JUrol 28: 53–62.13381) Rosen RC. Assessment of sexual dysfunction in patients with benign prostatichyperplasia.
BJU Int.2006;97(Suppl 2):29–33.82) Rosen RC, Cappelleri JC, Gendrano N., 3rd The International Index of ErectileFunction (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–44.83) Rosen RC, Catania JA, Althof SE, Pollack LM, O’Leary M, et al.Development and validation of four-item version of Male Sexual HealthQuestionnaire to assess ejaculatory dysfunction.
Urology. 2007;69:805–9.84) Rosen RC, Catania J, Pollack L, Althof S, O’Leary M, et al. Male SexualHealth Questionnaire (MSHQ): scale development and psychometricvalidation. Urology. 2004;64:777–82.85) Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, et al. Theinternational index of erectile function (IIEF): a multidimensional scale forassessment of erectile dysfunction.
Urology. 1997;49:822–30.86) Schulman C.С.,; Temml C.,; EAU BHP Guidelines., 2010.87) Shah HN, Mahajan AP, Hegde SS, Bansal MB. Peri-operative complicationsof holmium laser enucleation of the prostate: experience in the first 280 patients,and a review of literature. BJU Int. 2007;100:94–101.88) Shah HN, Sodha HS, Kharodawala SJ, Khandkar AA, Hegde SS, Bansal MB.Influence of prostate size on the outcome of holmium laser enucleation of theprostate. BJU Int.
2008;101:1536–1541.89) Shimizu N, Matsumoto S, Yoshioka N, Hanai T, Sugiyama T, et al.(2006) Clinical study of acute urinary retention. Nihon Hinyokika GakkaiZasshi 97: 839–843.90) Song SH, Son H, Kim KT, Kim SW, Moon du G, et al. Effect of tamsulosin onejaculatory function in BPH/LUTS. Asian J Androl. 2011;13:846–50.91) Suardi N, Gallina A, Salonia A, Briganti A, Deho F, et al. (2009) Holmiumlaser enucleation of the prostate and holmium laser ablation of the prostate:indications and outcome. Curr Opin Urol 19: 38–43.13492) Sung Han Kim, Hyung-Kook Yang, Hahn-Ey Lee, Jae-Seung Paick, SeungJune Oh. HoLEP does not affect the overall sexual function of BPH patients: aprospective study.
Asian J Androl. 2014 Nov-Dec; 16(6): 873–877.93) Sung Han Kim, Changwon Yoo, Minsoo Choo, Jae-Seung Paick, Seung-JuneOh. Factors Affecting De Novo Urinary Retention after Holmium LaserEnucleation of the Prostate. PLoS One. 2014; 9(1).94) Tan A, Liao C, Mo Z, Cao Y (2007) Meta-analysis of holmium laserenucleation versus transurethral resection of the prostate for symptomatic prostaticobstruction. Br J Surg 94: 1201–1208 .95) Terai A, Ichioka K, Matsui Y, Yoshimura K. Association of lower urinary tractsymptoms with erectile dysfunction in Japanese men. Urology.
2004;64:132–6.96) Tibaek S, Klarskov P, Lund Hansen B, et al. Pelvic floor muscle trainingbefore transurethral resection of the prostate: A randomized, controlled, blindedstudy. Scand J Urol Nephrol 2007; 41: 329–34.97) Tyson MD, Lerner LB. Safety of holmium laser enucleation of the prostate inanticoagulated patients.
J Endourol 2009; 23: 1343–6.98) Tyson MD, van Rij S, Briganti A, Gilling P, Gilling PJ. In 2013, holmiumlaser enucleation of the prostate (HoLEP) may be the new ‘gold standard’ CurrUrol Rep. 2012;13:427–32.99) Yael W. Bipolar saline TURP eliminates risk of dilutional hyponatremia.Urology 2004; 64: 298-301.100) Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of theprostate versus transurethral resection of the prostate: a systematic review andmeta-analysis of randomized controlled trials. J Endourol.2013;27:604–611.101) Zagone RL, Waldmann TM, Conlin MJ. Fragmentation of uric acid calculiwiththeholmium:YAGlaserproducescyanide.LasersSurgMed2002;31(4):230–2.135.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
